Aparicio Urtasun, J., Virgili Manrique, A. C., Capdevila Castillón, J., Muñoz Boza, F., Galván, P., Richart, P., . . . Maurel, J. (2022). Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab.
Citación estilo ChicagoAparicio Urtasun, Jorge, et al. Randomized Phase II Trial of FOLFIRI-panitumumab Compared With FOLFIRI Alone in Patients With RAS Wild-type Circulating Tumor DNA Metastatic Colorectal Cancer Beyond Progression to First-line FOLFOX-panitumumab. 2022.
Cita MLAAparicio Urtasun, Jorge, et al. Randomized Phase II Trial of FOLFIRI-panitumumab Compared With FOLFIRI Alone in Patients With RAS Wild-type Circulating Tumor DNA Metastatic Colorectal Cancer Beyond Progression to First-line FOLFOX-panitumumab. 2022.